Palisades Investment Partners’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.53M	Sell	40,203 -493	-1%	-$67.8K	2.42%	17
2025 Q1	$7.34M	Buy	40,696 +217	+0.5%	+$39.1K	3.68%	8
2024 Q4	$6.34M	Buy	40,479 +3,436	+9%	+$538K	2.68%	15
2024 Q3	$6.74M	Buy	37,043 +2,356	+7%	+$429K	2.94%	14
2024 Q2	$6.37M	Buy	+34,687	New	+$6.37M	3.15%	12